Web References

Adams FH et alEffect of tracheal instillation of natural surfactant in premature lambs. Clinical and autopsy findings. Pediatr Res. 1978;12:841-848.
Ainsworth et alPumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks’ gestation: a randomized trial.  Lancet. 2000;355:1387-1392.
Avery ME et alSurface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child. 1959;97:517-523.
Bloom BT et alComparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of RDS. Pediatrics. 1997;100:31-38.
Bose C et alImproved outcome at 28 days of age for very low birth-weight infants treated with a single dose of a synthetic surfactant. J Pediatr. 1990;117:947-953.
Chu J et alNeonatal pulmonary ischemia. Clinical and physiologic studies. Pediatrics. 1967;40:709-782.
Clark RH et alA comparison of the outcomes of neonates treated with two different natural surfactants. 
J Pediatr. 2001;139:828-831.
Collaborative European Surfactant replacement therapy for severe respiratory distress syndrome; an international randomized clinical trial. Pediatrics. 1988;82:683-69.
Corbet A et alDecreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trial. J Pediatr. 1991;118:595-605.
Enhorning G et alTracheal deposition of surfactant before the first breath. Am Rev Respir Dis. 1973;22:126-132.
Enhorning G et alPrevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: A randomized clinical trial. Pediatrics. 1985;76:145-153.
Fujiwara T et al Artificial surfactant therapy in hyaline membrane disease. Lancet. 1980;1:55-59.
Gitlin JD et al Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics. 1987;79:31-37.
Gortner L et al A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome. Lung. (suppl); 1990;168:864-869.
Gruenwald P et al Surface tension as a factor in the resistance of neonatal lungs to aeration. Am J Obstet Gynecol. 1947;53:996-1007.
Hallman M et al Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome. Pediatrics. 1983;71:473-482.
Hallman M et al Exogenous human surfactant for treatment of severe respiratory distress syndrome. A randomized, prospective clinical trial. J Pediatr. 1985;106:963-969.
Hoekstra RE et al Improved neonatal survival following multiple doses of bovine surfactant in very premature infants at risk for respiratory distress syndrome. Pediatrics. 1991;88:10-18.
Horbar JD et al A multicenter randomized placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med. 1989;320:959-965.
Horbar JD et al A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr. 1993;123:757-766.
Hudak ML et al A multicenter randomized masked comparison of natural vs synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr. 1996;128:396-406.
Hudak ML et al A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. Pediatrics. 1997;100:39-50.
King DM et al Bulk shear viscosities of endogenous and exogenous lung surfactants. Am J Physiol Lung Cell Mol Physiol. 2002;282:L277-84.
Kobayashi T et al A case of isiopathic respiratory distress syndrome treated by newly developed surfactant (Surfactant CK). J Jpn Med Soc Biol Interface. 1981;12:1-6.
Kwong MS et al A double blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics. 1985;76:585-592.
Liechty EA et al Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics. 1991;88:19-28.
Long W et al A controlled trial of synthetic surfactant in infants weighing 1,250g or more with respiratory distress syndrome. N Engl J Med. 1991;325:1696-1703.
Merritt TA et al Prophylactic treatment of very premature infants with human surfactant. N Engl J Med. 1986;315:785-790.
Morley CJ et al Dry artificial lung disease surfactant and its effect on very premature babies. Lancet. 1981;1:64-68.
Notter RH et al Lung surfactants basic science and clinical applications. Lung Biology in Health and Disease. 2000;149:Marcel-Dekker.
Notter RH et al Component-specific surface and physiological activity in bovine-derived lung surfactants. Chem Phys Lipids. 2002;114:21-34.
Robillard E et al Microaerosol administration of synthetic β,γ-dipalmitoyl-L-α-lecithin in the respiratory distress syndrome. A preliminary report. Can Med Assoc J. 1964;90:55-57.
Rollins M et al Comparison of clinical responses to natural and synthetic surfactants. J Perinat Med. 1993;21:341-347.
Sehgal SS et al Modified bovine surfactant (Survanta) vs a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: A pilot study. J Natl Med Assoc. 1994;86:46-52.
Smyth J et alHyaline membrane disease treated with bovine surfactant. Pediatrics. 1983;71:913-917.
Speer CP et al Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child. 1995;72:F8-F13.
Ten Centre Study Group Ten center trial of artificial surfactant (artificial lung expanding compound ALEC) in very premature babies. Br Med J. 1987;294:991-996.
Vermont-Oxford A multicenter randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics. 1996;97:1-6.
Von Neergaard KNeue auffassungen uber einen grundbegriff der atemmechanik. Doeretraltionskraft der lunge, adhangig von der oberflachenspannung in den alveolen. Z Ges Exp Med. 66:373-394.
Wilkinson A et al Two controlled trials of dry artificial surfactant: early effects and later outcome in babies with surfactant deficiency. Lancet. 1985;2:287-291.
Willson DF et al Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Crit Care Med. 1999;27:188-195.